Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Since their discovery approximately 25 years ago, adenosine receptors have now emerged as important novel molecular targets in disease and drug discovery. These proteins play important roles in the entire spectrum of disease from inflammation to immune suppression. Because of their expression on a number of different cell types and in a number of different organ systems they play important roles in specific diseases, including asthma, rheumatoid arthritis, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, heart disease, stroke, cancer, sepsis, and obesity. As a result of intense…mehr
Since their discovery approximately 25 years ago, adenosine receptors have now emerged as important novel molecular targets in disease and drug discovery. These proteins play important roles in the entire spectrum of disease from inflammation to immune suppression. Because of their expression on a number of different cell types and in a number of different organ systems they play important roles in specific diseases, including asthma, rheumatoid arthritis, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, heart disease, stroke, cancer, sepsis, and obesity. As a result of intense investigations into understanding the molecular structures and pharmacology of these proteins, new molecules have been synthesized that have high specificity for these proteins and are now entering clinical trials. These molecules will define the next new classes of drugs for a number of diseases with unmet medical needs.
to Adenosine Receptors as Therapeutic Targets.- A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers.- Recent Developments in Adenosine A2A Receptor Ligands.- Recent Developments in A2B Adenosine Receptor Ligands.- Medicinal Chemistry of the A3 Adenosine Receptor: Agonists, Antagonists, and Receptor Engineering.- Adenosine Receptors and the Heart: Role in Regulation of Coronary Blood Flow and Cardiac Electrophysiology.- Adenosine Receptors and Reperfusion Injury of the Heart.- Adenosine Receptors and Inflammation.- A1 Adenosine Receptor: Role in Diabetes and Obesity.- A3 Adenosine Receptor: Pharmacology and Role in Disease.- Adenosine Receptors and Asthma.- Adenosine Receptors, Cystic Fibrosis, and Airway Hydration.- Adenosine Receptors in Wound Healing, Fibrosis and Angiogenesis.- Adenosine Receptors and Cancer.- Adenosine Receptors and the Kidney.- Adenosine Receptors and the Central Nervous System.- Adenosine Receptors and Neurological Disease: Neuroprotection and Neurodegeneration.- Adenosine A2A Receptors and Parkinson’s Disease.- Adenosine Receptor Ligands and PET Imaging of the CNS.
to Adenosine Receptors as Therapeutic Targets.- A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers.- Recent Developments in Adenosine A2A Receptor Ligands.- Recent Developments in A2B Adenosine Receptor Ligands.- Medicinal Chemistry of the A3 Adenosine Receptor: Agonists, Antagonists, and Receptor Engineering.- Adenosine Receptors and the Heart: Role in Regulation of Coronary Blood Flow and Cardiac Electrophysiology.- Adenosine Receptors and Reperfusion Injury of the Heart.- Adenosine Receptors and Inflammation.- A1 Adenosine Receptor: Role in Diabetes and Obesity.- A3 Adenosine Receptor: Pharmacology and Role in Disease.- Adenosine Receptors and Asthma.- Adenosine Receptors, Cystic Fibrosis, and Airway Hydration.- Adenosine Receptors in Wound Healing, Fibrosis and Angiogenesis.- Adenosine Receptors and Cancer.- Adenosine Receptors and the Kidney.- Adenosine Receptors and the Central Nervous System.- Adenosine Receptors and Neurological Disease: Neuroprotection and Neurodegeneration.- Adenosine A2A Receptors and Parkinson’s Disease.- Adenosine Receptor Ligands and PET Imaging of the CNS.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/neu